Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RHOQ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NT5C3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAPSS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TINF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DLL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCGF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C7orf49 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHACTR4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANGEL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLA-DQB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAMTSL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAST - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPATS2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFI16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on